Evidence map›Paper›PMID 34326920›Full record

ArticleOxidative medicine and cellular longevity2021

Impact of Physical Activity on Oxidative Stress Markers in Patients with Metastatic Breast Cancer.

Lidia Delrieu, Marina Touillaud, Olivia Pérol, Magali Morelle, Agnès Martin, Christine M Friedenreich, Pauline Mury, Armelle Dufresne, Thomas Bachelot, Pierre-Etienne Heudel and 3 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03148886 (Advanced Breast Cancer and Lifestyle Exercise Study), which is not on this map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
1.5field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03148886 nacompletednot on this map

Advanced Breast Cancer and Lifestyle Exercise Study

TypeinterventionalSponsorCentre Leon BerardRan2016 to 2018Enrolled51ConditionsMetastatic BreastcancerArmsPA intervention
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Lidia DelrieuInter-University Laboratory of Human Movement Biology EA7424, University Claude Bernard Lyon 1, University of Lyon, Lyon, France.ORCID https://orcid.org/0000-0003-1240-5390
Marina TouillaudDepartment of Cancer and Environment, Léon Bérard Cancer Center, Lyon, France.ORCID https://orcid.org/0000-0001-9900-5861
Olivia PérolDepartment of Cancer and Environment, Léon Bérard Cancer Center, Lyon, France.ORCID https://orcid.org/0000-0002-7543-7050
Magali MorelleDepartment of Clinical Research and Innovation, Léon Bérard Cancer Center, Lyon, France.ORCID https://orcid.org/0000-0002-4694-4918
Agnès MartinInter-University Laboratory of Human Movement Biology EA7424, University Claude Bernard Lyon 1, University of Lyon, Lyon, France.ORCID https://orcid.org/0000-0003-0297-1823
Christine M FriedenreichDepartment of Cancer Epidemiology and Prevention Research, Cancer Care Alberta, Alberta Health Services, Calgary, Alberta, Canada.ORCID https://orcid.org/0000-0002-4783-1966
Pauline MuryInter-University Laboratory of Human Movement Biology EA7424, University Claude Bernard Lyon 1, University of Lyon, Lyon, France.ORCID https://orcid.org/0000-0001-5202-7078
Armelle DufresneDepartment of Medical Oncology, Léon Bérard Cancer Center, Lyon, France.ORCID https://orcid.org/0000-0002-6637-3526
Thomas BachelotDepartment of Medical Oncology, Léon Bérard Cancer Center, Lyon, France.ORCID https://orcid.org/0000-0002-0866-9484
Pierre-Etienne HeudelDepartment of Medical Oncology, Léon Bérard Cancer Center, Lyon, France.ORCID https://orcid.org/0000-0002-8555-8921
Béatrice FerversDepartment of Cancer and Environment, Léon Bérard Cancer Center, Lyon, France.ORCID https://orcid.org/0000-0003-3498-6499
Olivier TrédanDepartment of Medical Oncology, Léon Bérard Cancer Center, Lyon, France.ORCID https://orcid.org/0000-0001-5881-9383
Vincent PialouxInter-University Laboratory of Human Movement Biology EA7424, University Claude Bernard Lyon 1, University of Lyon, Lyon, France.ORCID https://orcid.org/0000-0003-2057-061X
Centre de Recherche en Cancérologie de Lyon · FRUniversité Claude Bernard Lyon 1 · FRInserm · FRAlberta Health Services · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeRegular physical activity (PA) can affect oxidative stress, known to be involved in carcinogenesis. The objective of this study was to evaluate the associations between a six-month PA intervention and oxidative stress biomarkers, PA, and clinical outcomes in patients with metastatic breast cancer.

methodsForty-nine newly diagnosed patients with metastatic breast cancer were recruited for a single-arm, unsupervised, and personalized six-month walking intervention with activity tracker. PA level and PA fitness, plasma concentrations of DNA oxidation (8OhdG), lipid peroxidation (MDA), and protein oxidation (AOPP), plasma activities of superoxide dismutase (SOD), glutathione peroxidase (GPX), and catalase, plasma and leucocyte activities of myeloperoxidase (MPO) and NADPH oxidase (NOX), and clinical markers of tumor progression (RECIST criteria) were measured at baseline and after the six-month intervention.

resultsGPX activity (+17%) and MDA (+9%) significantly increased between baseline and the end of the intervention. Changes in PA level and fitness were significantly positively correlated with changes in plasma GPX and significantly negatively with changes in NOX in the leucocytes. Plasma MDA was significantly higher (+20%) whereas plasma AOPP was lower (-46%) for patients with tumor progression or that died during the six months as compared to patients without progression.

conclusionA six-month PA intervention may be potentially beneficial in metastatic breast cancer patients for enhancing antioxidant enzyme activity and decreasing prooxidant enzyme activity. Moreover, AOPP and MDA could also be favorable and unfavorable biomarkers, respectively, since they are associated with disease progression and fitness level in this population. This trial is registered with NCT number: NCT03148886.

Indexed as

AdolescentAdultAgedBreast NeoplasmsExerciseFemaleHumansMiddle AgedNeoplasm MetastasisOxidative StressYoung Adult

Identifiers

PMID34326920
PMCPMC8302399
OpenAlexW3186080933

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.